Circulating aggregated platelets, number of platelets per aggregate and platelet size in chronic dialysis patients

J Winkler1, J Fuchs, G Morduchowicz

  • 1Institute of Hypertension and Kidney Diseases, Rabin Medical Center, Petah Tikva, Israel.

Nephron
|January 1, 1997
PubMed

Insights

Chronic dialysis patients exhibit significant platelet function abnormalities, contributing to their high rates of cardiovascular disease (CVD). These platelet changes, distinct from platelet count, indicate increased risk for atherosclerosis and related complications.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Hematology

Background:

  • Accelerated arteriosclerosis is a common, multifactorial complication in chronic dialysis patients.
  • Both non-uremic and uremic patients with atherosclerosis display functional platelet abnormalities.
  • Understanding platelet function is crucial for addressing cardiovascular morbidity in dialysis populations.

Purpose of the Study:

  • To investigate platelet function in patients undergoing chronic dialysis.
  • To correlate observed platelet function parameters with the presence of cardiovascular morbidity.
  • To elucidate the role of platelet abnormalities in the etiology of cardiovascular disease (CVD) in dialysis patients.

Main Methods:

  • Study included 53 chronic dialysis patients, assessing cardiovascular disease (CVD) risk factors and clinical manifestations.
  • Platelet function was evaluated using the modified Wu and Hoak method.
  • Key parameters measured: platelet count, aggregation (total, reversible, irreversible), platelets per aggregate, and large platelet percentage.

Main Results:

  • Dialysis patients showed significant differences in totally, reversibly, and irreversibly aggregated platelets compared to controls (p < 0.0001).
  • The percentage of large platelets (p < 0.0001) and average platelets per aggregate (p < 0.001) were significantly higher in dialysis patients.
  • No significant differences in platelet count or effects of dialysis modality (hemodialysis vs. peritoneal dialysis) or duration were observed.

Conclusions:

  • Chronic dialysis patients exhibit distinct platelet function abnormalities, including altered aggregation patterns and increased large platelets.
  • These platelet abnormalities are integral to the multifactorial etiology of advanced cardiovascular disease (CVD) in this population.
  • The identified platelet dysfunctions may predispose chronic dialysis patients to cardiovascular complications.

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...